Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancerScience Magazine1Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, 3584CT Utrech… Continue reading
OncLiveNovel Immunotherapy Approaches Moving Through RCC PipelineOncLiveZibelman: I spoke about novel immunotherapy options for patients with kidney cancer. I reviewed immunotherapy options that are currently out there with the PD-1 pathway blockade. … Continue reading
Medical XpressNeurotoxicity characterized after infusion of CD19 CAR-T cellsMedical XpressJuliane Gust, M.D., Ph.D., from the University of Washington in Seattle, and colleagues characterized neurologic adverse events in 133 adults with refractory B-ce… Continue reading
Science Trends (blog)A Novel Strategy To Enhance Immunotherapy By Interleukin 2 Tethered To Its ReceptorScience Trends (blog)It is now accepted that NK cells limited success in many immunotherapy strategies is due to the inability of NK cells to compet… Continue reading
New Stem Cell Treatment for Diffuse Scleroderma Patients Available at Okyanos Center for Regenerative MedicineScleroderma NewsA new treatment using adipose-derived regenerative cells (ADRCs) to treat hand problems caused by scleroderma is now available… Continue reading
Wall Street Journal |
Immunotherapy Treatments for Cancer Gain Momentum
Wall Street Journal The science of using immunotherapy to treat cancer is advancing rapidly, marked by the National Cancer Institute’s recent disclosure that a metastatic breast-cancer patient is now cancer-free, regulators’ expected approval of a major lymphoma treatment … NIH partners with 11 leading biopharmaceutical companies to accelerate the development of new cancer …National Institutes of Health (press release) US NIH teams up with 11 companies to speed cancer immunotherapy researchXinhua To accelerate new cancer treatments, NIH will team up with pharma on immunotherapy researchSTAT EurekAlert (press release) –The Hill –Reuters all 11 news articles » |
Newsweek |
Gene Therapy: How a New Cure for Blindness Reverses Retinal Dystrophy
Newsweek A Food and Drug Administration committee is considering whether a gene therapy touted as a breakthrough for people with a particular genetic form of blindness is effective. An FDA approval for the treatment, Luxturna, would be a landmark event for gene … FDA Vote Sets Stage for Gene Therapy’s FutureMIT Technology Review The Time Has Come: 4 Gene Therapy Stocks to Buy, 1 to AvoidBarron’s Live updates: FDA advisory panel reviews Spark’s gene therapySTAT Philly.com –WebMD –ABC News all 19 news articles » |